Skip to main content
Clinical Trials/NCT04162730
NCT04162730
Unknown
N/A

Validity, Reliability and Responsiveness of Pain Sensitization Questionnaire

Acibadem University1 site in 1 country150 target enrollmentJanuary 8, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain Syndrome
Sponsor
Acibadem University
Enrollment
150
Locations
1
Primary Endpoint
Pain Sensitivity Questionnaire
Last Updated
4 years ago

Overview

Brief Summary

The aim of this study was to translate the Pain Sensitivity Questionnaire, which was developed to determine the level of pain sensitivity of individuals, to Turkish and to evaluate the validity and reliability of the Turkish version of the scale on knee osteoarthritis patients, and as well as to perform cultural adaptation. Pain sensitivity assessment is used to predict treatment or surgical outcomes of individuals. IPain Sensitivity Questionnaire is a frequently used scale that correlates with experimental pain tests and is used in studies conducted in different patient groups. We believe that adding this scale to our language will contribute to other studies in this field.

Registry
clinicaltrials.gov
Start Date
January 8, 2020
End Date
December 28, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Acibadem University
Responsible Party
Principal Investigator
Principal Investigator

Özgül Öztürk

Principal Investigator

Acibadem University

Eligibility Criteria

Inclusion Criteria

  • Not having oral or written communication problems in Turkish,
  • Diagnosis of knee osteoarthritis after clinical examination and radiological imaging,
  • Being 40 years or older,
  • To have neurological competence and cognitive level to answer scale questions.

Exclusion Criteria

  • To have fibromyalgia syndrome or neurological disease that may affect pain sensitivity levels of individuals,
  • To have undergone surgery involving the knee in the last 1 year,
  • The presence of peripheral neuropathy and neuropathy is therefore to be taking medication.

Outcomes

Primary Outcomes

Pain Sensitivity Questionnaire

Time Frame: 1-4 week

The Pain Sensitivity Questionnaire was developed to visualize 17 situations that may feel pain in daily life and to indicate possible pain severity. The patient determines the pain severity level from 0 to 10, with 0 indicates no pain, and 10 indicates the most severe pain. The total score of the Pain Sensitivity Questionnaire and the two subscale scores, PSQ-minor and PSQ-moderate, can be calculated. The PSQ-moderate and PSQ-minor subscales consist of 7 items and the total score is calculated on 14 items. The other 3 items were excluded from the scoring of the scale as they normally indicate painless conditions. Total and subscale scores ranged from 0 to 10, and higher scores indicate increased pain sensitivity.

Secondary Outcomes

  • Pain Catastrophization Scale(1-4 week)
  • Pressure Pain Threshold(One day)

Study Sites (1)

Loading locations...

Similar Trials